Second Division, Department of Internal Medicine, Hamamatsu University School of Medicine, 1-20-1 Handayama, Higashi-ku, Hamamatsu, Shizuoka, 431-3192, Japan.
Department of Clinical Pharmacology and Therapeutics, Hamamatsu University School of Medicine, 1-20-1 Handayama, Higashi-ku, Hamamatsu, 431-3192, Japan.
BMC Pulm Med. 2022 May 8;22(1):186. doi: 10.1186/s12890-022-01983-3.
Mucociliary clearance (MCC) is an essential defense mechanism in airway epithelia for removing pathogens from the respiratory tract. Impaired ciliary functions and MCC have been demonstrated in asthma and chronic obstructive pulmonary disease (COPD). Long-acting muscarinic antagonists (LAMAs) are a major class of inhaled bronchodilators, which are used for treating asthma and COPD; however, the effects of LAMAs on ciliary function remain unclear. This study aimed to identify the effects of LAMAs on airway ciliary functions.
Wild-type BALB/c mice were treated with daily intranasal administrations of glycopyrronium for 7 days, and tracheal samples were collected. Cilia-driven flow and ciliary activity, including ciliary beat frequency (CBF), ciliary beating amplitude, effective stroke velocity, recovery stroke velocity and the ratio of effective stroke velocity to recovery stroke velocity, were analyzed by imaging techniques. Using in vitro murine models, tracheal tissues were transiently cultured in media with/without LAMAs, glycopyrronium or tiotropium, for 60 min. Cilia-driven flow and ciliary activity were then analyzed. Well-differentiated normal human bronchial epithelial (NHBE) cells were treated with glycopyrronium, tiotropium, or vehicle for 60 min, and CBF was evaluated. Several mechanistic analyses were performed.
Intranasal glycopyrronium administration for 7 days significantly increased cilia-driven flow and ciliary activity in murine airway epithelium. In the murine tracheal organ culture models, treatment with glycopyrronium or tiotropium for 60 min significantly increased cilia-driven flow and ciliary activity in airway epithelium. Further, we confirmed that 60-min treatment with glycopyrronium or tiotropium directly increased CBF in well-differentiated NHBE cells. In the mechanistic analyses, neither treatment with glycopyrronium nor tiotropium affected intracellular calcium ion concentrations in well-differentiated NHBE cells. Glycopyrronium did not increase protein kinase A activity in well-differentiated NHBE cells. Moreover, glycopyrronium had no effect on extracellular adenosine triphosphate concentration.
LAMAs exert a direct effect on airway epithelium to enhance ciliary function, which may improve impaired MCC in asthma and COPD. Further investigations are warranted to elucidate the underlying mechanisms of the effects of LAMAs on the promotion of airway ciliary function.
黏液纤毛清除(MCC)是气道上皮清除呼吸道病原体的重要防御机制。在哮喘和慢性阻塞性肺疾病(COPD)中,已经证明纤毛功能和 MCC 受损。长效抗胆碱能药物(LAMA)是一类主要的吸入性支气管扩张剂,用于治疗哮喘和 COPD;然而,LAMA 对纤毛功能的影响尚不清楚。本研究旨在确定 LAMA 对气道纤毛功能的影响。
野生型 BALB/c 小鼠每天经鼻内给予格隆溴铵治疗 7 天,采集气管标本。采用成像技术分析纤毛驱动流和纤毛活动,包括纤毛摆动频率(CBF)、纤毛摆动幅度、有效冲程速度、恢复冲程速度和有效冲程速度与恢复冲程速度的比值。在体外鼠模型中,气管组织在含有/不含 LAMA、格隆溴铵或噻托溴铵的培养基中短暂培养 60 分钟。然后分析纤毛驱动流和纤毛活动。用格隆溴铵、噻托溴铵或载体处理分化良好的正常人支气管上皮(NHBE)细胞 60 分钟,评估 CBF。进行了几种机制分析。
鼻内给予格隆溴铵治疗 7 天可显著增加小鼠气道上皮的纤毛驱动流和纤毛活动。在鼠气管器官培养模型中,60 分钟给予格隆溴铵或噻托溴铵治疗可显著增加气道上皮的纤毛驱动流和纤毛活动。此外,我们证实,60 分钟的格隆溴铵或噻托溴铵处理可直接增加分化良好的 NHBE 细胞的 CBF。在机制分析中,格隆溴铵或噻托溴铵处理均不影响分化良好的 NHBE 细胞内钙离子浓度。格隆溴铵不增加分化良好的 NHBE 细胞中的蛋白激酶 A 活性。此外,格隆溴铵对细胞外三磷酸腺苷浓度没有影响。
LAMA 对气道上皮有直接作用,可增强纤毛功能,可能改善哮喘和 COPD 中受损的 MCC。需要进一步研究阐明 LAMA 促进气道纤毛功能的潜在机制。